Why are med schools offering classes on structural racism, you ask?

Because of Henrietta Lacks
Because of the Tuskegee Study
Because of experimental procedures on enslaved Black women
Because of unnecessary procedures on women in ICE detention centers
Because if you are Black or

Ensuring patients with #cancer are well-informed about clinical trials is crucial!

Proud to share our JAMA Oncology patient page, dedicated to ⬆️ inclusion & diversity in trial enrollment— #patienteducation is an important first step!

👥🔗 jamanetwork.com/journals/jamao…

OncoAlert #lcsm

Challenges with Diversity in Clinical Trials and how community oncologists can help overcome these disparities. by Joshua Richter, MD, FACP
#mmsm #racialdisparities .

targetedonc.com/view/challenge…

'With so many risk factors identified, it may start to feel like every patient has high risk MM. Soon we may be asking a better question: Who actually has standard-risk disease?”. For ASCO news...Risky Business: The Challenge With Defining High-Risk MM ascopubs.org/doi/10.1200/AD…

We're #TwitterOfficial everyone! Please follow Miami Hematology Oncology Program Director for updates related to our Hem-Onc Fellows Network #Hematology #Oncology Sylvester Comprehensive Cancer Center Jackson Health System fellowship

Priscila Barreto Coelho, MD Thomas Platé IV Asaad Trabolsi Raleigh Ayo Fatoki, MD, MBA @MariamBird Deborah Soong Sunil Iyer, MD Steve Bialick, DO

Second day on inpatient service and we have a NET consult!! Perfect opportunity to teach my team and get them interested in Neuroendocrine Oncology. Looks like they are sold!! 😀 🦓Sylvester Comprehensive Cancer Center Miller Medicine

Latinos, Hispanics are more likely to get certain leukemias, but why? wlrn.org/health/2023-04… Sylvester Comprehensive Cancer Center Stephen D. Nimer, MD Mikkael A. Sekeres MD, MS Justin Watts MD Erin Kobetz #leusm #leukemia #cancer #healthdisparities #CancerMoonshot #CancerResearch

So excited for my first oral abstract presentation! #ASH2022 ASH

Please join Dr. Estela Rodriguez and me tomorrow at 8PM EST for a whirlwind tour of ✂️neoadjuvant⚕️ IO therapy for resectable NSCLC! 🫁

Delighted to contribute to #LCAM22 with this special #TumorBoardTuesday 💊🧬

In this #BreastCancerAwarenessMonth video with #OncData , Dr. Samuel Kareff, MD, MPH provides a comprehensive overview of #breast cancer therapies, serving as a valuable resource for patients discussing these options with their #oncology team:

oncdata.com/news/an-introd…

#BCAM #BCSM

Manni Mohyuddin Raleigh Ayo Fatoki, MD, MBA A perfect example of the power of Twitter to enable positive relationships, extend mentorship possibilities, and result in meaningful work. 👏

So proud to have mentored ⁦Raleigh Ayo Fatoki, MD, MBA⁩ on this research projecting looking at global myeloma trials and access.

And we finally met for the first time now!

#mmsm

SO BASICALLY THEY SEND YOU A SWAB KIT AND YOU JUST SWAB YOUR CHEEKS AND SEND THE KIT BACK AND THEY ADD YOU TO THE DONOR REGISTRY AND THEN YOU COULD POTENTIALLY SAVE SOMEONE’S LIFE ONE DAY

Done with boards 📚

Next up: International Myeloma Symposium in LA 🩸☀️

I can’t wait to meet some of the “Myelebrities” whose tweets and papers I’ve been obsessively reading for the past 3 years.

#IMS #IMS 2022 #mmsm

Huge thank you to Manni Mohyuddin and our team for bringing this project to life.

This was a cross-country, virtual collaboration powered by #MedTwitter and Hem-Onc Fellows Network network! 💪🏿